HEALTH TECHNOLOGY

Tegria Acquires KenSci in Order to Assist Healthcare Organizations in Gaining New Insights from Data

Tegria | June 28, 2021

Tegria announced today the purchase of KenSci, a leader in artificial intelligence systems and healthcare applications with origins in Microsoft's Azure4Research program and the University of Washington.

 

KenSci, which was founded in 2015, has received recognition for its AI platform and solutions that integrate the latest descriptive and predictive analytics technology, assisting healthcare organizations in modernizing their workflows and powering a digital, data-driven, value-based healthcare system. Customers of KenSci, which include providers, payers, and medical device manufacturers, are using advanced analytics and artificial intelligence in their operational, clinical, and care workflows, thus enhancing care experiences and health outcomes. KenSci applications are based on responsible and explainable AI models that aid in making healthcare more efficient, fair, and accountable.

 

Its services are cloud-based and built on Microsoft Azure. Customers of KenSci have also benefitted from the company's strong relationships with industry leaders. In 2020, Microsoft honored KenSci, its US Healthcare Partner of the Year.

 

"Unlocking data to provide insights is the key to making healthcare better for everyone," said Wasif Rasheed, Providence's chief revenue and growth officer. Tegria is set to debut in October 2020. "KenSci has been assisting clients in getting more out of their data for many years, and they understand the critical roles that innovation and collaboration play in accelerating change across all aspects of care. KenSci, when combined with Tegria's industry expertise and a wide variety of solutions, has the potential to have a significant effect on healthcare worldwide. KenSci has arrived in Tegria, and we couldn't be happier."

 

KenSci's AI-powered platform draws insights from data, resulting in improved patient experiences, more accurate diagnoses, and more efficient processes. KenSci automates data preparation across many sources, including real-time and unstructured data, and maps it into the industry-standard schema, preparing it for machine learning models. KenSci's platform is also designed to be versatile and customizable, allowing clients to build their applications.

 

"If you can predict, you have the potential to influence and enhance health outcomes," stated Sudarshan Chitre, CEO of KenSci. "AI and advanced analytics technologies are changing how healthcare companies use data to enhance human health and care outcomes. Tegria will allow us to expedite this transition on a larger scale while also providing instant value to our clients via AI-driven insights. We are thrilled to be joining Tegria so that we may write the next chapter together."

 

KenSci's technology is supported by substantial peer-reviewed research published by The Institute of Electrical and Electronics Engineers (IEEE), The Association for Computing Machinery (ACM), The American Medical Informatics Association (AMIA), and other organizations. KenSci received HIMSS Health Innovation Awards in 2018 and 2019 and KLAS top ratings in healthcare AI in 2019 and 2020. KenSci was a Gartner Cool Vendor and a CMS AI Challenge finalist in 2019. KenSci is headquartered in Seattle and has offices in Singapore and India.

 

With KenSci, Tegria can expand the breadth and depth in electronic health record optimization, managed services, revenue cycle management, and other areas. KenSci will continue to serve its existing client base while also working with its new colleagues on integrated solutions for the global healthcare industry.

 

Tegria's financial advisor was Cascadia Capital, and its legal counsel was McDermott Will & Emery on this deal. Brentwood Capital Advisors served as the exclusive financial adviser for KenSci, while Wilson Sonsini Goodrich & Rosati acted as legal counsel.

 

About Tegria

Tegria, founded by Providence, is dedicated to creating health for a better world. Tegria assists healthcare organizations of all sizes in accelerating technological, clinical, and operational advancements that enable people to live the healthiest lifestyles possible. Tegria is a Seattle-based company with employees throughout the United States and internationally. It employs over 3,000 strategists, technologists, service providers, and scientists committed to providing value to customers.

Spotlight

Colorectal cancer patient Garry Laxtal, 53, and Dr. Gregg Nelson, Surgical Lead for Enhanced Recovery After Surgery (ERAS) Alberta, discuss a Surgery Strategic Clinical Network project that’s shortening hospital lengths of stay, speeding recoveries and improving outcomes for surgical patients.

Spotlight

Colorectal cancer patient Garry Laxtal, 53, and Dr. Gregg Nelson, Surgical Lead for Enhanced Recovery After Surgery (ERAS) Alberta, discuss a Surgery Strategic Clinical Network project that’s shortening hospital lengths of stay, speeding recoveries and improving outcomes for surgical patients.

Related News

HEALTH TECHNOLOGY

Amwell Honors Leading Healthcare Organizations for Telehealth Excellence and Advancing in Digital Care Delivery

Amwell | April 30, 2021

Amwell®, a national telehealth leader, named the winners of its annual Client Awards Program today. Organizations that showed a deep contribution to improving healthcare through empowering providers, developing new models of treatment, deploying innovative integrations, and closing care inequalities are honored with awards. Also during the pandemic, these organizations exemplified telehealth excellence and paved the way for new and innovative approaches to delivering and extending safe access to quality care. “COVID-19 put a strain on the whole healthcare industry, but our clients have not only risen to the occasion, demonstrating unparalleled strength and resilience, but they have also pushed the boundaries of what is possible through telehealth and have used technology to reimagine care delivery models and innovate experiences to better serve their providers, members, and patients,” said Ido Schoenberg, MD, Chairman and co-CEO of Amwell. “We are incredibly grateful for the chance to help and empower so many of the world's leading healthcare agencies as they work to expand access to more affordable, high-quality care and improve outcomes for all.” The winners were named at Amwell's annual Client Forum and were chosen from four categories, with preference given to organizations that made a meaningful difference through their telehealth activities. Empowering Providers: For partnering with providers to enhance the virtual care experience for long-term adoption: • Hawai’i Medical Service Association (HMSA); and • Horizon Health Services New Models, New Normal: For successfully adapting care delivery models to respond to rapidly changing healthcare circumstances: • Cook County Health; and • Northwell Health Innovative Integrations: For identifying connection points within digital healthcare to improve clinical outcomes and user experiences: • AdventHealth; and • Anthem Inc. Positive Impact: For proven success using telehealth to improve population needs and close inequities in care: • Blue Cross Blue Shield of Arizona; • M Health Fairview; • MedStar Health; and • National Association of Letter Carriers Health Benefit Plan About Amwell Amwell is a leading telehealth platform in the United States and around the world, connecting and empowering providers, insurers, patients, and innovators to provide more accessible, better quality care. Amwell claims that digital care delivery would have a transformative impact on healthcare. The company has a single, all-inclusive platform to serve all telehealth needs, including critical, acute, and post-acute care, as well as chronic care management and healthy living. Amwell has more than a decade of experience providing telehealth solutions for over 2,000 hospitals and over 55 health plan partners with over 36,000 employers, covering over 80 million lives.

Read More

HEALTH TECHNOLOGY

XCO and Atlazo Form Partnership to Commercialize Virtual Healthcare Products Using Edge AI System-on-Chip Technology

XCO,Atlazo | May 11, 2021

XCO Tech Inc. what's more, Atlazo, Inc. has declared the arrangement of Recon Health Inc., a joint dare to market an arrangement of cutting edge virtual medical services items dependent on inserted computerized reasoning (AI) edge figuring and clinical based investigation. The main item being created by the joint endeavor is a novel clinical gadget with installed AI for constant wellbeing observing. The gadget will give clinical-grade, across-the-board multi-sensor far off persistent checking of basic indispensable signs to address the developing need specialists and medical caretakers have for target patient information during telehealth arrangements and keeping in mind that giving other computerized wellbeing administrations. The gadget will likewise enable patients at home with clinical evaluation information and will give fundamental examination that will help the clinical determination and therapy of constant ailments like cardiovascular, respiratory, and neurodegenerative illnesses. The mix of Atlazo's reality driving implanted Health System-on-Chip with XCO's BioAnalytics information stage and item configuration experience will furnish Recon Health with accurate clinical gadgets that have an unmistakable serious edge in the quickly developing virtual consideration market. "Specialists today don't believe information coming from customer wearables, and most clinical gadgets don't give the usability that buyers expect because they require huge information stockpiling and battery capacity to gather and investigate the information through distributed computing," said Scott McMillan, fellow benefactor and CEO of XCO. "The keen edge figuring utilized by Recon Health's gadget defeats these difficulties by fusing Atlazo's Health-System-on-a-Chip (HSoC) innovation." "The inherent AI is a critical progression in edge figuring for clinical consideration. The AI and elite figuring motor on the chip dissects high goal sensor signals at high testing rates and reports the key measurements and data to the patient employing BLE," said Dr. Karim Arabi, fellow benefactor and CEO of Atlazo, Inc. "The outcome is information that specialists can trust, patients can comprehend, and gadgets that can be worn for quite a long time without re-energizing." The gadget will be the first multi-essential sign clinical gadget to latently quantify blood oxygen immersion alongside breath rate, pulse, pulse inconstancy, center internal heat level, and activity levels. Future forms are relied upon to extend in usefulness by adding pulse, ECG heart rhythms examination, and sound for hack and discourse-based comprehension investigation. About XCO XCO is reclassifying how to survey physical, biometric, and psychological execution across the range of wellbeing and maturing. An innovator in R&D and commercialization, the organization's arrangement of exclusive equipment and programming wire world-driving movement following, psychological result measures and multi-sensor biometric observing, giving ongoing evaluations to medical care and game. About Atlazo Atlazo is a pioneer inconsistently on AI processors, sensor interface plan, and energy the executives for minuscule edge gadgets. The organization gets bleeding-edge developments hyper-low force semiconductor plan, on-gadget AI preparing, and exact detecting.

Read More

HEALTH TECHNOLOGY

Centene Corporation Acquires Apixio

Centene Corporation | November 09, 2020

Centene Corporation (NYSE: CNC) today declared it has consented to a conclusive arrangement to acquire Apixio Inc., a healthcare investigation organization offering Artificial Intelligence (AI) innovation arrangements. The exchange is dependent upon administrative endorsements and is required to near to the furthest limit of 2020. Apixio gives an innovation suite that mines, arranges and investigates huge volumes of dissimilar, unstructured patient information, (for example, doctor notes and clinical graphs), and makes and refines calculations to remove excellent bits of knowledge to help payers' and suppliers' regulatory exercises. Apixio's AI stage has been prepared to deal with the complexities and difficulties of the healthcare business and convey demonstrated outcomes. "Centene is committed to accelerating innovation, modernization and digitization across the enterprise and solidify its position as a technology company focused on healthcare. Apixio's capabilities are closely aligned with our plans to digitize the administration of healthcare and to leverage comprehensive data to help improve the lives of our members," said Michael F. Neidorff, Chairman, President and Chief Executive Officer for Centene. "Apixio's technology will complement existing data analytics products including Interpreta, creating a differentiated platform to broaden support for value-based healthcare payment and delivery with actionable intelligence." "We are very excited about this transaction. With Centene, we will be able to accelerate the use of our AI technology to improve the way that healthcare is measured, administered, and delivered, and to help enable new discoveries," said Darren Schulte, M.D., Chief Executive Officer for Apixio. "This partnership positions Apixio to extract insights from digital data to help millions of individuals receive higher quality care around the world." Apixio will stay an operationally free substance as a component of Centene's Health Care Enterprises gathering to keep carrying an incentive to its customers and the business, while likewise understanding the advantages of upgraded scale with Centene. AboutCentene Corporation Centene Corporation, a Fortune 50 company, is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person.Centenefocuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners.

Read More